Dermatologic Therapy
Q1 Journal
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Dermatology
Q1
└
Medicine (miscellaneous)
Q2
Publisher
Citation Score 2025
0.796
Q1
Citation Score
H-Index
90
Citations / Doc (2yr)
1.01
Total Docs. (latest)
118
Total Citations (3yr)
1,924
Publication type
Journals
ISSN
13960296, 15298019
Coverage
1996-2026
Journal Rank
#6,962
Subject Categories
Dermatology
Q1
Medicine (miscellaneous)
Q2
Subject Areas
Aims & Scope
Dermatologic Therapy has been created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities.
Each issue of the journal consists of a series of scholarly review articles written by leaders in dermatology in which they describe, in very specific terms, how they treat particular cutaneous diseases and how they use specific therapeutic agents.
The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations.
Because of the specific and practical nature of this publication, Dermatologic Therapy not only serves as a readily available resource for the day-to-day treatment of patients, but also as an evolving therapeutic textbook for the treatment of dermatologic diseases.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 118 |
| Total Docs. (3 years) | 919 |
| Total Refs. | 4,824 |
| Total Citations (3 years) | 1,924 |
| Citable Docs. (3 years) | 554 |
| Citations / Doc. (2 years) | 1.01 |
| Ref. / Doc. | 40.88 |
| % Female | 51.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.